• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Columbus – Presentation of interim report Q3 2025

COLUM07.11.2025, 11.00
HC Andersen Capital

You can already now sign up for the event and send in your questions. You don’t have to participate live to submit questions for the event.

Columbus expects to release its Q3 2025 interim report on November 6, 2025. The next day at 11:00 AM CET, Columbus’ CEO & President, Søren Krogh Knudsen, and CFO, Brian Iversen, will present the results and answer questions from the audience during a live online event.

In the first half of 2025, and especially in Q2, Columbus was affected by macroeconomic uncertainty, leading to prolonged sales cycles and postponed IT project decisions. Revenue declined by 4% in Q2 2025 (6% decline adjusted for currency effects). EBITDA amounted to DKK 16 million for the quarter, compared to DKK 22 million in Q2 2024 (adjusted for other operating income and expenses). The EBITDA margin was 4% in Q2, versus 7% in the same period last year.

In connection with the Q2 2025 report the company maintained the guidance adjusted in mid-July. Full-year revenue is expected to be in line with 2024, at approx. DKK 1.7 billion, with an EBITDA margin of 7–9%. For the first half of 2025, total revenue was DKK 843 million, guidance representing a decline of around 3%. The EBITDA margin for the first half was 7.4%.

In addition to the Q3 2025 financial results, focus will be on market conditions and whether the company sees any positive change in the current depressed situation, and how Columbus is managing keeping efficiency up in this environment.

Columbus is a Danish-listed global IT services and consulting company, specializing in digital transformation with a main focus in the manufacturing, retail & distribution, food & beverage, and life science industries. Headquartered in Denmark and with offices and partners across many parts of the world, Columbus advises, implements, and manages IT solutions within the areas Dynamics 365, M3, Digital Commerce, Data & AI, and Other Local Business. The Columbus share is listed on Nasdaq Copenhagen (Ticker: COLUM).

Disclaimer: HC Andersen Capital receives payment from Columbus for a Digital IR subscription agreement. /Michael Friis 12.58, 3 October 2025.

Kommende selskabspræsentationer

Seneste videoer

Implantica, Audiocast, Q2'26
21.08.2026, 15.00 Implantica
SP Group – Presentation of the quarterly report for Q2 2026
21.08.2026, 15.00 SP Group
Egetis Therapeutics, Audiocast, Q2'26
21.08.2026, 14.00 Egetis Therapeutics
North Media – Præsentation af regnskabet for 2. kvartal 2026
21.08.2026, 14.00 North Media
WindowMaster – Presentation of H1 2026 Interim Report
21.08.2026, 13.00 WindowMaster International
Vis alle videoer